Skip to content
value.today

Concord Biotech Limited

CONCORDBIO.NS
$1.2 Bmarket cap on Nov 19, 2026
1D
-0.7%
Compare
World rank
#8,316
Revenue
—
annual
Net income
—
Employees
—

Concord Biotech Limited in brief

Concord Biotech Limited is a listed company in the Healthcare sector, based in India. Its market value was $1.2 B on 19 November 2026, which makes it the 8,316th largest listed company in the world and the 557th largest in India on this site.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Concord Biotech Limited timeline

1 events, 2023
  1. 2023
  2. 📈
    Listed on National Stock Exchange of India as CONCORDBIO
    First day of listing in the exchange's official list.

Events of Concord Biotech Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Concord Biotech Limited share price · NSE (CONCORDBIO.NS)

daily · 801 trading days since 2023
Last close 556.40 INR (Nov 19, 2026)1 month: -56.7%1 year: -61.6%52-week range 545.90 – 1,615 INR
$0 M$702 M$1.4 B$2.1 B$2.8 B202420252026
DateOpenHighLowCloseChangeVolume
Nov 19, 2026556.00561.00549.10556.40-0.8%272,032
Nov 18, 2026546.80566.30545.90561.00+1.1%570,378
Nov 17, 2026584.40584.40553.50554.80-4.5%690,494
Nov 16, 2026595.70596.00577.90581.00-2.2%331,037
Nov 13, 2026604.30612.00588.70594.00-1.3%154,642
Nov 12, 2026600.00604.40595.80601.80+0.8%196,543
Nov 11, 2026607.80614.10594.90597.20+0.1%244,658
Nov 9, 2026615.00625.20592.50596.80-5.7%413,912
Nov 6, 2026656.00663.00622.30632.60-6.0%259,305
Nov 5, 2026660.00684.00654.00672.70+2.6%372,203
Nov 4, 2026608.00662.00594.60655.50-46.6%355,637
Nov 3, 20261,1731,2481,1671,228+5.5%337,197
Nov 2, 20261,2081,2101,1561,164-6.6%408,684
Oct 30, 20261,2241,2721,2151,246+1.2%103,692
Oct 29, 20261,2651,2811,2271,231-3.0%174,733
Oct 28, 20261,3201,3331,2631,269-7.8%380,222
Oct 27, 20261,3091,3941,2981,375+4.9%157,342
Oct 26, 20261,2251,3251,2251,311+6.7%185,480
Oct 23, 20261,2711,2801,2131,229-3.3%96,706
Oct 22, 20261,2701,3091,2531,271+0.1%93,347
Oct 21, 20261,2671,2841,2511,270-1.2%83,316
Oct 19, 20261,3501,3501,2761,286-4.0%79,842
Oct 16, 20261,3631,3671,3321,339-1.1%45,381
Oct 15, 20261,3911,3951,3501,353-2.1%35,984
Oct 14, 20261,3791,3961,3721,382+0.9%63,724
Oct 13, 20261,3551,3751,3361,370+1.1%67,678
Oct 12, 20261,3681,3891,3501,354-0.5%53,163
Oct 9, 20261,3361,3701,3261,361+2.3%128,354
Oct 8, 20261,3601,3711,3101,331-2.1%181,142
Oct 7, 20261,3731,3801,3561,360—43,657

Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.

Concord Biotech Limited share price statistics

computed nightly from the daily prices
NSE · CONCORDBIO.NSClose 556.40 INR (Nov 19, 2026)
1 day
-0.8%
1 week
-7.5%
1 month
-56.7%
3 months
-65.0%
Year to date
-58.6%
1 year
-61.6%
3 years
-56.5%
5 years
—
10 years
—
52-week low 545.90-65.5% from the highhigh 1,615
Highest on record 2,664 INR (Sep 20, 2024)Volume 219,350 shares/dayValue traded 191.9 M INR/dayVolatility 187% (30d), 76% (1y)801 trading days on record

Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.

Market cap history

$0 M$362 M$723 M$1.1 B$1.4 B

World rank over time

▼ down 258 places since 2026
2026-11-12: #8059#8,05920262026-11-13: #8137#8,13720262026-11-16: #8157#8,15720262026-11-17: #8356#8,35620262026-11-18: #8307#8,30720262026-11-19: #8317#8,3172026

Rank in India: #541 (Nov 2026) · #543 (Nov 2026) · #543 (Nov 2026) · #562 (Nov 2026) · #557 (Nov 2026) · #557 (Nov 2026)

Mutual funds holding Concord Biotech Limited#

39 funds in 2 countries hold shares worth $87 M. Since their previous reports 16 added shares and 7 sold, buying $3 M net. By country: India 13 ($61 M), USA 26 ($25 M).
Mutual funds holding Concord Biotech Limited
FundSharesValueOf the companyOf the fundChange in sharesReport
🇮🇳 DSP Small Cap FundDSP Asset Managers2.62 M$34 M—1.6%no changeOct 31, 2026
🇮🇳 SBI Healthcare Opportunities FundSBI Funds Management960,000$13 M—2.0%no changeOct 31, 2026
🇮🇳 DSP Healthcare FundDSP Asset Managers735,820$10 M—2.5%no changeOct 31, 2026
🇺🇸 Aberdeen India Fund, Inc.ABRDN Asia Limited460,707$6 M—1.1%no changeJun 30, 2026
🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc.397,583$6 M—<0.01%+3.9%Jul 31, 2026
🇺🇸 Vanguard Emerging Markets Stock Index FundThe Vanguard Group, Inc.361,053$5 M—<0.01%no changeJul 31, 2026
🇺🇸 iShares Core MSCI Emerging Markets ETFBlackRock Fund Advisors283,390$3 M—<0.01%+27%May 31, 2026
🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc.115,718$2 M—0.01%+4401%Jul 31, 2026
🇮🇳 SBI Balanced Hybrid FundSBI Funds Management120,000$2 M—0.75%no changeOct 31, 2026
🇮🇳 Nippon India Pharma FundNippon Life India Asset Management111,738$1 M—0.15%no changeOct 31, 2026
🇮🇳 Nippon India Nifty Smallcap 250 Index FundNippon Life India Asset Management49,074$1 M—0.20%−4.0%Oct 31, 2026
🇺🇸 WisdomTree India Earnings FundWisdomTree Asset Management, Inc.38,578$1 M—0.02%−5.6%Jun 30, 2026
🇺🇸 iShares MSCI India Small-Cap ETFBlackRock Fund Advisors45,634$1 M—0.08%−8.7%May 31, 2026
🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc.32,437$0 M—0.06%−2.9%Jun 30, 2026
🇮🇳 SBI Nifty Smallcap 250 Index FundSBI Funds Management26,140$0 M—0.20%+0.7%Oct 31, 2026
🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc.19,807$0 M—<0.01%no changeJul 31, 2026
🇮🇳 Motilal Oswal Nifty Smallcap 250 Index FundMotilal Oswal Asset Management18,419$0 M—0.20%+0.0%Oct 31, 2026
🇺🇸 WisdomTree Emerging Markets SmallCap Dividend FundWisdomTree Asset Management, Inc.13,381$0 M—0.01%−1.1%Jun 30, 2026
🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP10,847$0 M—<0.01%newJul 31, 2026
🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP7,968$0 M—<0.01%+9.1%Jul 31, 2026
🇺🇸 State Street Global All Cap Equity ex-U.S. Index PortfolioSSGA Funds Management, Inc.8,583$0 M—<0.01%no changeJun 30, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC8,412$0 M—<0.01%−57%Jun 30, 2026
🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP7,295$0 M—<0.01%newJul 31, 2026
🇮🇳 Nippon India Nifty 500 Equal Weight Index FundNippon Life India Asset Management6,387$0 M—0.18%+0.7%Oct 31, 2026
🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP5,502$0 M—<0.01%+25%Jul 31, 2026
🇺🇸 iShares MSCI Emerging Markets Small-Cap ETFBlackRock Fund Advisors7,257$0 M—0.02%no changeMay 31, 2026
🇮🇳 Motilal Oswal Nifty 500 Index FundMotilal Oswal Asset Management5,421$0 M—0.02%+2.0%Oct 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP4,053$0 M—<0.01%newJul 31, 2026
🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc.4,855$0 M—<0.01%no changeMay 31, 2026
🇮🇳 Motilal Oswal Nifty Smallcap 250 ETFMotilal Oswal Asset Management3,662$0 M—0.20%−1.3%Oct 31, 2026
🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP3,218$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets Sustainability Core 1 ETFDimensional Fund Advisors LP2,198$0 M—<0.01%newJul 31, 2026
🇺🇸 Emerging Markets ex China Core Equity PortfolioDimensional Fund Advisors LP2,052$0 M—<0.01%newJul 31, 2026
🇺🇸 FlexShares Morningstar Emerging Markets Factor Tilt Index FundNorthern Trust Investments, Inc.1,288$0 M—<0.01%no changeJul 31, 2026
🇮🇳 SBI Nifty 500 Index FundSBI Funds Management1,283$0 M—0.02%+1.6%Oct 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP897$0 M—<0.01%newJul 31, 2026
🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP692$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust831$0 M—<0.01%no changeMay 31, 2026
🇮🇳 Motilal Oswal Nifty 500 ETFMotilal Oswal Asset Management514$0 M—0.02%no changeOct 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Oct 31, 2026. The 39 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Where Concord Biotech Limited operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for Concord Biotech Limited: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

Concord Biotech Limited: countries of operation
CountryPresenceRevenue there
🇮🇳 IndiaHeadquarters—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

FDA drug approvals: Concord Biotech Limited#

5 approved applications held; 1 approvals and 0 new uses in 2026.

Approvals held
5
New molecular entities
0
New uses approved
0
efficacy supplements
Generics
5
0 new drugs, 0 biologics
Concord Biotech Limited: latest FDA approvals
ApprovedDrugKind
2026-06-09Tofacitinib CitrateTofacitinib Citrate · ANDA218821Generic drug (ANDA)
2020-11-10TacrolimusTacrolimus · ANDA213112Generic drug (ANDA)
2020-07-31Mycophenolate MofetilMycophenolate Mofetil · ANDA212087Generic drug (ANDA)
2019-12-13Mycophenolate SodiumMycophenolate Sodium · ANDA211173Generic drug (ANDA)
2019-01-08Mycophenolate MofetilMycophenolate Mofetil · ANDA210181Generic drug (ANDA)

Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (CONCORD BIOTECH LTD), so they follow acquisitions

Discuss Concord Biotech Limited#

1 automatic updates and 0 member comments. Sign in to comment and react.

  • Mutual funds: 39 funds hold $87 millionautomatic update · Oct 31, 2026

    39 mutual funds in 2 countries hold shares of Concord Biotech Limited worth $87 million (funds' newest reports, up to 31 October 2026). Since their previous reports 16 funds added shares and 7 sold; on balance they bought $3 million. Share splits are not counted as trading.

How Concord Biotech Limited compares in Healthcare

CompanyMarket capP/ENet marginRev. growth
Concord Biotech Limited🇮🇳$1.2 B———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Nov 19, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Concord Biotech Limited? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Concord Biotech Limited's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Concord Biotech Limited? Suggest a correction